Sesamol-loaded solid lipid nanoparticles for treatment of skin cancer

Journal of Drug Targeting

Volumn 23, Issue 2, 2015, Pages 159-169

  Geetha, T ^a   Kapila, Meenakshi ^a   Prakash, Om ^b   Deol, Parneet Kaur ^a   Kakkar, Vandita ^a   Kaur, Indu Pal ^a  

^a PANJAB UNIVERSITY   (India)

^b LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

Anticancer; Glycery monostearate; Oxidative stress; Pharmacodynamics; Topical

Indexed keywords

ALPHA TOCOPHEROL; ANTINEOPLASTIC AGENT; ANTIOXIDANT; ASCORBIC ACID; BENZO[A]PYRENE; CATALASE; GLUTATHIONE; MALONALDEHYDE; REACTIVE OXYGEN METABOLITE; SESAMOL; SOLID LIPID NANOPARTICLE; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG; 1,3 BENZODIOXOLE DERIVATIVE; DRUG CARRIER; NANOPARTICLE; PHENOL DERIVATIVE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; CANCER CELL LINE; CELL DEATH; CONTROLLED STUDY; DIFFERENTIAL SCANNING CALORIMETRY; DNA FRAGMENTATION; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG ELIMINATION; DRUG PENETRATION; DRUG SOLUBILITY; DRUG SOLUTION; DRUG STABILITY; DRUG STORAGE; EPIDERMIS HYPERPLASIA; HISTOPATHOLOGY; HL 60 CELL LINE; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; MTT ASSAY; NANOENCAPSULATION; NONHUMAN; PARTICLE SIZE; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; RAT; SKIN; SKIN CANCER; SKIN PERMEABILITY; TISSUE HOMOGENATE; ANIMAL; APOPTOSIS; CHEMISTRY; DRUG DESIGN; DRUG EFFECTS; DRUG FORMULATION; HUMAN; INBRED MOUSE STRAIN; METABOLISM; PATHOLOGY; SKIN ABSORPTION; SKIN NEOPLASMS; SURFACE PROPERTY;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; ANTIOXIDANTS; APOPTOSIS; BENZODIOXOLES; DRUG CARRIERS; DRUG COMPOUNDING; DRUG DESIGN; DRUG STABILITY; HL-60 CELLS; HUMANS; MALE; MICE, INBRED STRAINS; NANOPARTICLES; PARTICLE SIZE; PHENOLS; SKIN; SKIN ABSORPTION; SKIN NEOPLASMS; SURFACE PROPERTIES;

EID: 84921286891     PISSN: 1061186X     EISSN: 10292330     Source Type: Journal    
DOI: 10.3109/1061186X.2014.965717     Document Type: Article

References (55)

1. Orazio JD, Jarrett S, Amaro-Ortiz A, Scott T. UV radiation and the skin. Int J Molec Sci 2013;14:12222-48.
2. Lowe NJ. An overview of ultraviolet radiation, sunscreens, and photo-induced dermatoses. Dermatol Clin 2006;24:9-17.
3. Yaar M, Gilchrest BA. Photoageing: mechanism, prevention and therapy. Brit J Dermatol 2007;157:874-87.
4. Bickers DR, Athar M. Oxidative stress in the pathogenesis of skin diseases. J Invest Dermatol 2006;126:2565-75.
5. Ames BN, Durston WE, Yamasaki E, Lee FD. Carcinogens are mutagens: a simple test system combining liver homogenates for activation and bacteria for detection. Proc Natl Acad Sci USA 1973;70:2281-5.
6. Deol PK, Kaur IP. Improving the therapeutic efficiency of ginger extract for treatment of colon cancer using a suitably designed multiparticulate system. J Drug Target 2013;21:855-65.
7. Singh P, Kaur IP. Development and evaluation of a gastroretentive delivery system for improved antiulcer activity of ginger extract (Zingiber officinale). J Drug Target 2011;19:741-51.
8. Gupta A, Sharma S, Kaur IP, Chopra K. Renoprotective effects of sesamol in ferric nitrilotriacetate-induced oxidative renal injury in rats. Basic Clin Pharmacol Toxicol 2009;104:316-21.
9. Mishra K, Srivastava PS, Chaudhury NK. Sesamol as a potential radioprotective agent: in vitro studies. Radiat Res 2011;176: 613-23.
10. Narasimhan R, Vaithiyanathan M, Janardanam V. Neuroprotective effect of sesamol in glioma induced in rats. Biomed Int 2011;2: 22-7.
11. Geetha T, Bhandari R, Kaur IP. Sesamol: an efficient antioxidant with potential therapeutic benefits. J Med Chem 2009;5:367.
12. Kaur IP, Saini A. Sesamol exhibits antimutagenic activity against oxygen species mediated mutagenicity. Mutat Res 2000; 470:71-6.
13. Sharma S, Kaur IP. Development and evaluation of sesamol as an antiaging agent. Int J Dermatol 2006;45:200-8.
14. Kapadia GJ, Azuine MA, Tokuda H, et al. Chemopreventive effect of resveratrol, sesamol, sesame oil and sunflower oil in the Epstein- Barr virus early antigen activation assay and the mouse skin twostage carcinogenesis. Pharmacol Res 2002;45:499-505.
15. Lai F, Sinico C, De Logu A, et al. SLN as a topical delivery system for Artemisia arborescens essential oil: in vitro antiviral activity and skin permeation study. Int J Nanomed 2007;2:419-25.
16. Souto EB, Almeida AJ, Müller RH. Lipid nanoparticles (SLN®, NLC®) for cutaneous drug delivery: structure, protection and skin effects. J Biomed Nanotechnol 2007;3:317-31.
17. Kaur IP, Kapila M, Agrawal R. Role of novel delivery systems in developing topical antioxidants as therapeutics to combat photoaging. Ageing Res Rev 2007;6:271-88.
18. Müller RH, Runge SA, Ravelli V, et al. Cyclosporine-loaded solid lipid nanoparticles (SLN): drug-lipid physicochemical interactions and characterization of drug incorporation. Eur J Pharm Biopharm 2008;68:535-44.
19. Singh PK, Kaur IP. Synbiotic (probiotic and ginger extract) loaded floating beads: a novel therapeutic option in an experimental paradigm of gastric ulcer. J Pharm Pharmacol 2012;64:207-17.
20. Kakkar V, Mishra AK, Chuttani K, et al. Delivery of sesamol loaded solid lipid nanoparticles to brain for menopause related emotional and cognitive central nervous system derangements. Rejuvenat Res 2011;14:597-604.
21. Kakkar V, Muppu SK, Chopra K, Kaur IP. Curcumin loaded solid lipid nanoparticles: an efficient formulation approach for cerebral ischemic reperfusion injury in rats. Eur J Pharmaceut Biopharmaceut 2013;85:339-45.
22. Agrawal R, Kaur IP. Inhibitory effect of encapsulated curcumin on UV-induced photoageing in mice. Rejuvenat Res 2010;13: 397-410.
23. Supino R. In vitro toxicity testing protocols. In: Hare SO, Atterwill CK, eds. Methods in molecular biology. Vol. 43. Totowa, NJ: Humana Press; 1995:137-49.
24. Elsayed MMA, Abdallah OY, Naggar VF, Khalafallah NM. Lipid vesicles for skin delivery of drugs: reviewing three decades of research. Int J Pharmaceut 2007;332:1-16.
25. Singh B, Singh S. A comprehensive computer program for study of drug release kinetics from compressed matrices. Int J Pharmaceut 1998;60:313-17.
26. Cuppett SL, Wijeratne SSK, Schlegel V. Hydrogen peroxide induced oxidative stress damage and antioxidant enzyme response in caco-2 human colon cells. J Agric Food Chem 2005; 53:8768-74.
27. Schinella GR, Troiani G, Davila V, et al. Antioxidant effects of aqueous extract of Ilex paraguariensis. Biochem Biophys Res Commun 2000;269:357-60.
28. Ellman G. Tissue sulphydryl groups. Arch Biochem Biophys 1959; 32:70-7.
29. El-sokkarya GH, Cuzzocreab S, Reiterc RJ. Effect of chronic nicotine administration on the rat lung and liver: beneficial role of melatonin. Toxicology 2007;239:60-7.
30. Gornall AG, Bardawill CJ, David MM. Determination of serum proteins by means of the biuret reaction. J Biol Chem 1949;177: 751-66.
31. Schwarz C, Mehnert W, Lucks JS et al. Solid lipid nanoparticles (SLN) for controlled drug delivery: production, characterisation and sterilisation. J Control Release 1994;30:83-96.
32. Idson B, Lazarus J. Percutaneous absorption: semisolids. In: Lachman L, Liberman HA, Kanig JL, eds. The theory and practice of industrial pharmacy. Bombay, India: Varghese Publishing House; 1987:536-9.
33. AKS. 2014. Available from: http://www.aksci.com/item--detail.php?cat=365223 [last accessed 1 Aug 2014].
34. Wang Y, Zhu L, Dong Z, et al. Preparation and stability study of norfloxacin-loaded solid lipid nanoparticle suspensions. Colloid Surface B 2012;98:105-11.
35. Wong RSY. Apoptosis in cancer: from pathogenesis to treatment. J Exp Clin Cancer Res 2011;30:87-91.
36. Morgan DML. Tetrazolium (MTT) assay for cellular viability and activity. In: Morgan DML, ed. Polyamine protocols. Vol. 79. Totowa, NJ: Humana Press; 1998:179-84.
37. Manjunath K, Reddy JS, Venkateswarlu V. Solid lipid nanoparticles as drug delivery systems. Method Find Exp Clin Pharmacol 2005; 27:127-44.
38. Chen H, Chang X, Du D, et al. Podophyllotoxin-loaded solid lipid nanoparticles for epidermal targeting. J Control Release 2006;110: 296-306.
39. Kuchlera S, Herrmanna W, Minkinb GP, et al. SLN for topical application in skin diseases - characterization of drug-carrier and carrier-target interactions. Pharmaceut Nanotechnol 2010;390: 225-33.
40. Jenning V, Gysler A, Schäfer-Korting M, Gohla SH. Vitamin A loaded solid lipid nanoparticles for topical use: occlusive properties and drug targeting to the upper skin. Eur J Pharmaceut Biopharmaceut 2000;49:211-18.
41. Dingler A, Blum RP, Niehus H, et al. Solid lipid nanoparticles (SLNTM/LipopearlsTM) - a pharmaceutical and cosmetic carrier for the application of vitamin E in dermal products. J Microencapsul 1999;16:751-67.
42. Garti E. Effects of surfactants on crystallization and polymorphic transformatiom of fats and fatty acids. In: Garti K, Sato K, eds. Crystallization and polymorphism of fats and fatty acids. New York, Basel: Marcel Dekker; 1988:267-303.
43. Jenning V, Gohla S. Encapsulation of retinoids in solid lipid nanoparticles. J Microencapsul 2001;18:149-58.
44. Wissing SA, Muller RH. A novel sunscreen system based on tocopherol acetate incorporated into solid lipid nanoparticles. Int J Cosmetic Sci 2001;23:233-43.
45. Westesen K, Siekmann B, Koch MHJ. Investigations on the physical state of lipid nanoparticles by synchrotron X-ray diffraction. Int J Pharmaceut 1993;93:189-99.
46. Pardeshi C, Rajput P, Belgamwari V, et al. Solid lipid based nanocarriers: an overview. Acta Pharmaceut 2012;62: 433-72.
47. Siekmann B, Westesan K. Submicron-sized parenteral carrier systems based on solid lipids. Pharmaceut Pharmacol Lett 1992; 1:123-6.
48. Roessner A, Kuester D, Malfertheiner P, Schneider-Stock R. Oxidative stress in ulcerative colitis-associated carcinogenesis. Pathol Res Pract 2008;204:511-24.
49. Huang MT, Ho CT, Wang ZY, et al. Inhibition of skin tumorigenesis by rosemary and its constituents carnosol and ursolic acid. Cancer Res 1994;54:701-8.
50. Huang MT, Ma W, Yen P, et al. Inhibitory effects of topical application of low doses of curcumin on 12-O-tetradecanoyl phorbol-13-acetate induced tumor promotion and oxidised DNA bases in mouse epidermis. Carcinogenesis 1997;18:83-8.
51. Seven A, Civelek S, Inci E, et al. Evaluation of oxidative stress parameters in blood of patients with laryngeal carcinoma. Clin Biochem 1999;32:369-73.
52. Nordman R, Ribere C, Rouach H. Implication of free radical mechanisms in ethanol induced cellular injury. Free Radic Biol Med 1992;12:219-40.
53. Taniguchi M, Yasutake A, Takedomi K. Effect of N, Nitrosodimethylamine (NDMA) on the oxidative status of rat liver. Arch Toxicol 1999;73:1412-16.
54. Capdevila JH, Morrow JD, Belosludtsev YY, et al. The catalytic outcomes of the constitutive and the mitogen inducible isoforms of prostaglandin H synthetase are markedly affected by glutathione and glutathione peroxidase(s). Biochemistry 1995;34: 3325-37.
55. Bryant RW, Simon TC, Bailey JM. Role of glutathione peroxidase and monophosphate shunt in the platelet lipoxygenase pathway. J Biol Chem 1982;257:14937-43.